Table 2.
Clinical characteristics of mutation subtypes.
Genes | Biochemistry | Radiology | Molecular imaging |
---|---|---|---|
SDHx, FH | NE, MT, dopamine | MRI | 18F-FDG or 68Ga-Som PET |
VHL, EPAS1 | NE | CT | 18F-DOPA or 11C-HED PET |
RET | NE, E | CT | 18F-DOPA or 11C-HED PET |
NE, norepinephrine; E, epinephrine; FDG, fluorodeoxyglucose; Som, somatostatin receptor; DOPA, L-dihydroxyphenylalanine; HED, hydroxyephedrine; CT, computed tomography; MRI, magnetic resonance imaging; PET, positron emission tomographyMT, methoxytyramine.